Are PTH serum levels predictive of coronary calcifications in haemodialysis patients?

Nephrology Dialysis Transplantation

Volumn 22, Issue 11, 2007, Pages 3262-3267

  Coen, Giorgio ^a,h   Manni, Micaela ^b   Mantella, Daniela ^c   Pierantozzi, Andrea ^d   Balducci, Alessandro ^b   Condò, Stefano ^d   DiGiulio, Salvatore ^c   Yancovic, Lijljana ^e   Lippi, Basilio ^a   Manca, Simone ^f   Morosetti, Massimo ^e   Pellegrino, Luigi ^g   Simonetti, Giovanni ^g   Gallucci, Massimo Taccone ^f   Splendiani, Giorgio ^d  

^a Piazza San Bartolomeo All'Isola 21   (Italy)

^b SAN GIOVANNI ADDOLORATA HOSPITAL   (Italy)

^c SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

^e GB Grassi Hospital   (Italy)

^f FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^g TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^h NONE   (Italy)

Author keywords

Calcium coronary score; Chronic kidney disease; Haemodialysis; Low bone turnover; Serum iPTH

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALUMINUM; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCITRIOL; CALCIUM; CALCIUM CARBONATE; CALCIUM CHANNEL BLOCKING AGENT; CUPROPHANE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HELIXONE; PARATHYROID HORMONE; POLYCARBONATE; SEVELAMER; SPIRAFLO SG 8 PLUS; UNCLASSIFIED DRUG;

ADULT; ARTERY CALCIFICATION; ARTICLE; CALCIUM BLOOD LEVEL; COHORT ANALYSIS; DIABETES MELLITUS; FEMALE; HEMODIALYSIS PATIENT; HORMONE BLOOD LEVEL; HUMAN; HYPERTENSION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; BIOLOGICAL MARKERS; CALCINOSIS; COHORT STUDIES; CORONARY DISEASE; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PARATHYROID HORMONE; PREDICTIVE VALUE OF TESTS; RENAL DIALYSIS; RISK FACTORS;

EID: 36749040899     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm370     Document Type: Article

References (30)

1. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32 [5 Suppl. 3]: S112-S119
2. Cheung AK, Sarnak MJ, Yan G et al. Atherosclerotic cardiovascular disease risks in chronic hemodiaalysis patients. Kidney Int 2000; 58: 353-362
3. Coen G, Manni M, Agnoli A et al. Cardiac calcifications; Fetuin-A and other risk factors in hemodialysis patients. ASAIO J 2006; 52: 150-156
4. Ketteler M, Wanner C, Metzger T et al. Deficiency of calcium-regulatory proteins in dialysis patients: a novel concept of cardiovascular calcification in uremia. Kidney Int 2003; 63 [Suppl. 84]: S84-S87
5. Moe SM, Reslerova M, Ketteler M. Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD). Kidney Int 2005; 67: 2295-2304
6. Jono S, Ikari Y, Vermeer C et al. Matrix GLA protein is associated with coronary artery calcification as assessed by electron-beam computed tomography. Thromb Haemost 2004; 91: 790-794
7. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004; 15: 2208-2218
8. Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon T, Port FK. Associationof elevated serum PO4, Ca x PO4product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 2001; 12: 2131-2138
9. Parfitt AM. Renal bone disease: a new conceptual framework for the interpretation of bone histomorphometry. Curr Opin Nephrol Hypertens 2003; 12: 387-403
10. London GM, Marty C, Marchais SJ, Guerin AP, Metivier F, DeVernejoul MC. Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol 2004; 15: 1943-1951
11. Braun J. Extraosseous calcification in patients with chronic renal failure - no escape ? Nephrol Dial Transplant 2005; 20: 2054-2059
12. Moe SM. Vascular calcification and renal osteodystrophy relationship in chronic kidney disease. Eur J Clin Invest 2006; 36 [Suppl. 2]: 51-62
13. Kurz P, Monier Faugere MC, Bognar B et al. Evidence for abnormal calcium homeostasis in patients with adynamic bone disease. Kidney Int 1994; 46: 855-861
14. Wang AYM, Woo J, Lam CW et al. Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis, and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrol Dial Transplant 2005; 20: 1676-1685
15. Moe SM, O'Neill KD, Resterova M, Fineberg N, Parsohn S, Meyer C. Natural history of vascular calcification in dialysis and transplant patients. Nephrol Dial Transplant 2004; 19: 2387-2393
16. Matsuoka M, Iseki K, Tamashiro M et al. Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis. Clin Exp Nephrol 2004; 8: 54-58
17. Stenvinkel P, Pecoits-Filho R, Lindholm B. Coronary artery disease in end-stage renal disease: no longer a simple plumbing problem. J Am Soc Nephrol 2003; 14: 1927-1939
18. Stenvinkel P, Heimburger O, Lindholm B et al. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant 2000; 15: 953-60
19. Coco M and Rush H. Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. Am J Kidney Dis 2000; 36: 1115-1121
20. Young EW, Albert JM, Satayathum S et al. Predictors and consequences of altered mineral metabolism: the dialysis outcomes and practice patterns study. Kidney Int 2005; 67: 1179-1187
21. Slinin Y, Foley RN, Collins AJ. Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1,3, and 4 study. J Am Soc Nephrol 2005; 16: 1788-1793
22. Knez A, Becker A, Becker C et al. Detection of coronary calcinosis with multislice spiral computerized tomography: an alternative to electron beam tomography. Z Kardiol 2002; 91: 642-649
23. Costantini S, Giordano R, Vernillo I. Application of ZrC-coated to the determination of aluminium in serum by graphite furnace atomic absorption spectroscopy. Microchem J 1984; 30: 435-434
24. Coen G, Ballanti P, Bonucci E et al. Renal osteodystrophy in predialysis and hemodialysis patients: comparison of histologic patterns and diagnostic predictivity of intact PTH. Nephron 2002; 91: 103-111
25. Hutchison AJ, Whitehouse RW, Boulton HF et al. Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease. Kidney Int 1993; 44: 1071-1077
26. Qi Q, Monier-Faugere MC, Geng Z, Malluche HH. Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis. Am J Kidney Dis 1995; 26: 622-631
27. Couttenye MM, D'Haese PC, Van Hoof VO et al. Low serum levels of alkaline phosphatase of bone origin: a good marker of adynamic bone disease in hemodialysis patients. Nephrol Dial Transplant 1996; 11: 1065-1072
28. Oh J, Wunsch R, Turzer M et al. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 2002; 106: 100-105
29. Price PA, Roublick AM, Williamson MK. Artery calcification in uremic rats is increased by a low protein diet and prevented by treatment with ibandronate. Kidney Int 2006; 70: 1577-1583
30. Galassi A, Spiegel DM, Bellasi A, Block GA, Raggi P. Accelerated vascular calcification and relative hypoparathyroidism in incident haemodialysis diabetic patients receiving calcium binders. Nephrol Dial Transplant 2006; 21: 3215-3222